COMPANY OVERVIEW

SAB Biotherapeutics is developing and delivering technologies to transform the treatment and prevention of diseases from cancer and inflammation to autoimmune and influenza.

---

LOCATION

Sioux Falls, SD, USA

Cambridge, MA, USA

---

THERAPEUTIC AREAS

Infectious Disease

Oncology

---

WEBSITE

https://sabbiotherapeutics.com/

---

CAREER WEBSITE

https://sabbiotherapeutics.com/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

May 18, 2023

SAB Biotherapeutics Announces U.S. FDA Grants Breakthrough Therapy Designation to SAB-176 Influenza Immunotherapy

May 4, 2023

SAB Biotherapeutics Announces Appointment of Erick Lucera, CFA to Board of Directors

May 3, 2023

SAB Biotherapeutics to Present at Sidoti Virtual Investor Conference, May 10-11

Mar 23, 2023

ICR Hosts SAB Biotherapeutics CEO Eddie Sullivan on the Welcome to the Arena Podcast

Jan 18, 2023

SAB Biotherapeutics Receives an Additional $8.2 Million in Closeout of DoD Contract

For More Press Releases

---